Current and emerging utility of PARP inhibitors for the management of ovarian cancer
Event title | Website of the event | Main speciality | Name of the CME provider | Nature of ELM | Expiration date |
---|---|---|---|---|---|
Current and emerging utility of PARP inhibitors for the management of ovarian cancer | Website | Oncology | EPG Health | Individual module | 27/03/2025 |